172 related articles for article (PubMed ID: 33898426)
1. Transforming Growth Factor (TGF) β and Endometrial Vascular Maturation.
Lu Q; Sun D; Shivhare SB; Hou H; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Front Cell Dev Biol; 2021; 9():640065. PubMed ID: 33898426
[TBL] [Abstract][Full Text] [Related]
2. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
[TBL] [Abstract][Full Text] [Related]
3. Altered vascular smooth muscle cell differentiation in the endometrial vasculature in menorrhagia.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2014 Sep; 29(9):1884-94. PubMed ID: 25006206
[TBL] [Abstract][Full Text] [Related]
4. Reduced Transforming Growth Factor-β Activity in the Endometrium of Women With Heavy Menstrual Bleeding.
Maybin JA; Boswell L; Young VJ; Duncan WC; Critchley HOD
J Clin Endocrinol Metab; 2017 Apr; 102(4):1299-1308. PubMed ID: 28324043
[TBL] [Abstract][Full Text] [Related]
5. Menstrual cycle distribution of uterine natural killer cells is altered in heavy menstrual bleeding.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
J Reprod Immunol; 2015 Nov; 112():88-94. PubMed ID: 26398782
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of stromal cell-derived factor-1 (CXCL12) and circulating endothelial progenitor cells in women with idiopathic heavy menstrual bleeding.
Elsheikh E; Andersson E; Sylvén C; Ericzon BG; Palmblad J; Mints M
Hum Reprod; 2014 Jan; 29(1):49-56. PubMed ID: 24218400
[TBL] [Abstract][Full Text] [Related]
7. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.
Fergusson RJ; Bofill Rodriguez M; Lethaby A; Farquhar C
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD000329. PubMed ID: 31463964
[TBL] [Abstract][Full Text] [Related]
8. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated uterine natural killer cells and vascular remodeling in women with recurrent pregnancy losses.
El-Azzamy H; Dambaeva SV; Katukurundage D; Salazar Garcia MD; Skariah A; Hussein Y; Germain A; Fernandez E; Gilman-Sachs A; Beaman KD; Kwak-Kim J
Am J Reprod Immunol; 2018 Oct; 80(4):e13024. PubMed ID: 30066369
[TBL] [Abstract][Full Text] [Related]
10. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.
Lethaby A; Shepperd S; Cooke I; Farquhar C
Cochrane Database Syst Rev; 2000; (2):CD000329. PubMed ID: 10796528
[TBL] [Abstract][Full Text] [Related]
11. Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A.
Andersson E; Zetterberg E; Vedin I; Hultenby K; Palmblad J; Mints M
Int J Mol Med; 2015 Feb; 35(2):433-8. PubMed ID: 25504455
[TBL] [Abstract][Full Text] [Related]
12. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.
Fergusson RJ; Lethaby A; Shepperd S; Farquhar C
Cochrane Database Syst Rev; 2013 Nov; (11):CD000329. PubMed ID: 24288154
[TBL] [Abstract][Full Text] [Related]
13. Endometrial resection and ablation techniques for heavy menstrual bleeding.
Lethaby A; Penninx J; Hickey M; Garry R; Marjoribanks J
Cochrane Database Syst Rev; 2013 Aug; (8):CD001501. PubMed ID: 23990373
[TBL] [Abstract][Full Text] [Related]
14. Differential Gene Expression in Menstrual Endometrium From Women With Self-Reported Heavy Menstrual Bleeding.
Girling JE; Lockhart MG; Olshansky M; Paiva P; Woodrow N; Marino JL; Hickey M; Rogers PAW
Reprod Sci; 2017 Jan; 24(1):28-46. PubMed ID: 27189201
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
16. Endometrial protein expression and phosphorylation landscape decipher aberrant insulin and mTOR signalling in patients with recurrent pregnancy loss.
Chen C; Wen Q; Deng F; Li R; Wang Y; Zhen X; Hang J
Reprod Biomed Online; 2024 Jan; 48(1):103585. PubMed ID: 38016376
[TBL] [Abstract][Full Text] [Related]
17. Endometrial destruction techniques for heavy menstrual bleeding.
Lethaby A; Hickey M; Garry R
Cochrane Database Syst Rev; 2005 Oct; (4):CD001501. PubMed ID: 16235284
[TBL] [Abstract][Full Text] [Related]
18. Localization of angiogenic growth factors and their receptors in the human endometrium throughout the menstrual cycle and in recurrent miscarriage.
Lash GE; Innes BA; Drury JA; Robson SC; Quenby S; Bulmer JN
Hum Reprod; 2012 Jan; 27(1):183-95. PubMed ID: 22081249
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human endometrial transforming growth factor beta1 and beta3 isoforms through menstrual cycle and medroxyprogesterone acetate treatment.
Reis FM; Ribeiro MF; Maia AL; Spritzer PM
Histol Histopathol; 2002; 17(3):739-45. PubMed ID: 12168782
[TBL] [Abstract][Full Text] [Related]
20. Effect of early luteal phase administration of mifepristone (RU486) on leukaemia inhibitory factor, transforming growth factor beta and vascular endothelial growth factor in the implantation stage endometrium of the rhesus monkey.
Ghosh D; Kumar PG; Sengupta J
J Endocrinol; 1998 Apr; 157(1):115-25. PubMed ID: 9614365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
